RenovoRx, Inc.’s RenovoTAMP Platform On Pace To Change Cancer Treatment Landscape ($RNXT)
RenovoRx, Inc. (NASDAQ: RNXT) shares are bucking the bearish trend. Since the new year, RNXT stock has been trading higher by over 54%, decoupling from the broader weakness in the small-cap biotech space. With impressive YTD gains, RXNT is better positioned now than when its stock scored a $5.00 mark last month, and following its latest announcements, a more than 38% move higher in the near term could be in play. That bullish presumption is justified as the latest news








